ArticleJMIR cardio2026
Cardiac Telerehabilitation Using a Smartwatch and a Gamified Smartphone App: Single-Arm Pre-Post Feasibility Study.
Article in JMIR cardio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Home-based cardiac rehabilitation (CR) using digital health technologies (ie, cardiac telerehabilitation [CTR]) has emerged as a practical alternative to conventional center-based CR, particularly during and after the COVID-19 pandemic. However, maintaining sustained participation in CR remains challenging. Gamification holds the potential to enhance motivation and adherence in CR, but its role in CTR for patients with acute coronary syndrome (ACS) remains under-studied. Objective: This feasibility study evaluated the feasibility, acceptability, and safety of a combination of a gamification-enabled smartphone app and a smartwatch supporting CTR after ACS. We focused specifically on participation motivation, adherence to prescribed exercise intensity, and short-term physiological outcomes. Methods: This single-arm, pre-post intervention study was conducted at 2 Japanese institutions. Sixteen patients diagnosed with ST-elevated myocardial infarction or non-ST-elevated myocardial infarction and undergoing percutaneous coronary intervention were enrolled after discharge. Each patient received a smartphone and smartwatch connected to the Shin-po Kei app, through which participants earned points when exercising within their target anaerobic threshold heart rate (HR) range (±10 bpm). The 1-month intervention prescribed walking for 30 minutes or longer 3 to 5 days or more per week, at an intensity corresponding to a Borg scale score of 11 to 13. The primary end point was the number of app log-in days divided by the number of intervention days (app use rate). Secondary end points included the target HR exercise adherence rate (defined as the proportion of patients who exercised for 30 minutes within the target HR range on 3 or more days per week), changes in peak oxygen consumption, and changes in perceived exertion using a visual analog scale. Results: The mean patient age was 62 (SD 13) years, and 94% (15/16) were male. The mean intervention duration was 29 (SD 6) days, and the overall app use rate was 59.9%. The target HR exercise adherence rate was 50%. Peak oxygen consumption increased from 18.4 (SD 4.1) to 21.1 (SD 5.4) mL/kg/min, and the mean visual analog scale score for exercise-related hassle reduced from 57 (SD 33) to 32 (SD 26). No adverse events related to app use were identified, and 1 hospitalization unrelated to the intervention occurred during the study period. Conclusions: This feasibility study suggests that short-term engagement with a smartwatch-linked gamified smartphone app is achievable in CTR after ACS. However, adherence to predefined gamified exercise standards was lower than app use rates, suggesting that refinement of reward rules and target HR thresholds may be necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.